Literature DB >> 8847834

Close correlation between nitric oxide (NO) formation from NO releasers and the biological activities of these agents in rats.

Y Kita1, S Fukuyama, Y Hirasawa.   

Abstract

The aim of this study was to clarify the difference in the profiles of nitric oxide (NO) formation of three NO releasers and to examine the correlation between NO formation from these drugs and their biological activities in rats. (+/-)-(E)-ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexenamide (FK409) and 3-morpholinosydnonimine (SIN-1) spontaneously generated nitrite, an oxidative product of NO, in sodium phosphate buffer (PB) solution. On the other hand, sodium nitroprusside (SNP) did not generate nitrite. The rank order of the concentrations of nitrite generated was SIN-1 > FK409 >> SNP. In biological studies using rats, these drugs showed anti-platelet effects and in vitro vasorelaxant and hypotensive effects with potencies in the rank order of FK409 > SIN-1 > SNP and SNP > FK409 > SIN-1, respectively. These drugs generated nitrite with concentrations in the rank order of FK409 > SIN-1 > SNP and SNP > FK409 > SIN-1 in rat plasma and in PB solution with L-cysteine (Cys), respectively. In conclusion, three NO releasers liberate NO with NO-releasing rates of different rank orders under different incubation conditions, and the anti-platelet effects and vasorelaxant and hypotensive effects of these NO releasers closely correlate with NO formation from the compounds in the plasma and PB solution with Cys, respectively, but not with that in PB solution without Cys.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8847834     DOI: 10.1254/jjp.69.69

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  2 in total

1.  Decreased antipyrine clearance following endotoxin administration: in vivo evidence of the role of nitric oxide.

Authors:  K Kitaichi; L Wang; K Takagi; M Iwase; E Shibata; M Nadai; T Hasegawa
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

2.  Nitric oxide (NO)-releasing pathway of FK409 in the presence of sulfhydryl-bearing compounds.

Authors:  S Fukuyama; T Azuma; Y Hirasawa; N Morokoshi; T Akama; S Koda; Y Kita
Journal:  Pharm Res       Date:  1996-08       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.